Details for Patent: 9,186,346
✉ Email this page to a colleague
Which drugs does patent 9,186,346 protect, and when does it expire?
Patent 9,186,346 protects AUBAGIO and is included in one NDA.
Protection for AUBAGIO has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has one patent family member in one country.
Summary for Patent: 9,186,346
Title: | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients |
Abstract: | This invention relates to a method for managing the risk of an adverse interaction between teriflunomide and a substrate of breast cancer resistance protein (BCRP) and/or organic anion transporting polypeptide B1 and B3 (OATP1B1/B3). |
Inventor(s): | Weitz; Dietmar (Konigstein im Taunus, DE), Menguy-Vacheron; Francoise (Paris, FR), Clot; Pierre-Francois (Epinay sur Orge, FR), Turpault; Sandrine (Pennington, NJ) |
Assignee: | SANOFI (Paris, FR) |
Application Number: | 14/172,082 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,186,346 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,186,346
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | AUBAGIO | teriflunomide | TABLET;ORAL | 202992-001 | Sep 12, 2012 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Sanofi Aventis Us | AUBAGIO | teriflunomide | TABLET;ORAL | 202992-002 | Sep 12, 2012 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,186,346
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
13305130 | Feb 4, 2013 |
International Family Members for US Patent 9,186,346
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2762135 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |